mDixon ECG-gated 3-dimensional cardiovascular magnetic resonance angiography in patients with congenital cardiovascular disease.
Kourtidou, S; Jones, MR; Moore, RA; Tretter, JT; Ollberding, NJ; Crotty, EJ; Rattan, MS; Fleck, RJ; Taylor, MD.
Journal of Cardiovascular Magnetic Resonance.
2019;
21.
Conservative gadolinium administration to patients with Duchenne muscular dystrophy: decreasing exposure, cost, and time, without change in medical management.
Lang, SM; Alsaied, T; Moore, RA; Rattan, M; Ryan, TD; Taylor, MD.
International Journal of Cardiovascular Imaging.
2019;
35:2213-2219.
Can virtual heart transplantation via 3-dimensional imaging increase the maximum acceptable donor size?.
Szugye, NA; Lorts, A; Zafar, F; Taylor, M; Morales, DL S; Moore, RA.
Journal of Heart and Lung Transplantation.
2019;
38:331-333.
Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial.
Taylor, M; Jefferies, J; Byrne, B; Lima, J; Ambale-Venkatesh, B; Ostovaneh, MR; Makkar, R; Goldstein, B; Smith, RR; Fudge, J; et al.
Neurology.
2019;
92:e866-e878.
Evaluation of pulmonary artery stenosis in congenital heart disease patients using functional diagnostic parameters: An in vitro study.
D'Souza, GA; Banerjee, RK; Taylor, MD.
Journal of Biomechanics.
2018;
81:58-67.
Preserving myocardium in muscular dystrophy patients using ACE inhibition.
Taylor, MD.
Trends in Cardiovascular Medicine.
2018;
28:338-339.
Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy.
Starc, JJ; Moore, RA; Rattan, MS; Villa, CR; Gao, Z; Mazur, W; Jefferies, JL; Taylor, MD.
Pediatric Cardiology.
2017;
38:1485-1492.
Applications of cardiac magnetic resonance imaging in sickle cell disease.
Niss, O; Taylor, MD.
Blood Cells, Molecules, and Diseases.
2017;
67:126-134.
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.
Niss, O; Quinn, CT; Lane, A; Daily, J; Khoury, PR; Bakeer, N; Kimball, TR; Towbin, JA; Malik, P; Taylor, MD.
JACC-Cardiovascular Imaging.
2016;
9:243-252.
Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging.
Lang, SM; Shugh, S; Mazur, W; Sticka, JJ; Rattan, MS; Jefferies, JL; Taylor, MD.
Pediatric Cardiology.
2015;
36:1495-1501.